Trump administration aims to soften the blow by negotiating with insurers.

Medicare Part D premiums are set to rise sharply as a key federal subsidy is scaled back. The Trump administration plans to ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

Low-income beneficiaries are also feeling the squeeze. Enrollment in the Low-Income Subsidy (LIS) program dropped from 13.7 ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

To receive Medicare benefits, eligible people select either traditional Medicare or Medicare Advantage (MA)—options that differ markedly in cost, benefits, financial arrangements, and who pays ...

The Trump administration is also modifying the premium stabilization program implemented under President Joe Biden.

Health Secretary Robert F. Kennedy Jr. is promoting his plan to “fix” the system that HHS uses to compensate people injured ...

The average monthly bid submitted by insurers for 2026 prescription drug plans increased 33% from last year, according to data released by the CMS.

Shares of CVS Health jumped on Thursday after the healthcare giant posted better-than-expected second-quarter results and ...